-

03:24:57 PM

DGX Stock News

DGX - Quest Diagnostics, Inc.

10/18/21 7:01 AM

NYSE : DGX

Quest Diagnostics to Introduce Ki-67 IHC MIB-1 pharmDx, the First Companion Diagnostic for Eli Lilly and Company's Verzenio® (abemaciclib), a CDK4/6 Inhibitor for Certain People with HR+ HER2- High Risk Early Breast Cancer

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it will provide clinical laboratory testing using the Ki-67 IHC MIB-1 pharmDx (Dako Omnis) immunohistochemistry companion

RHEA-AI

very positive

10/12/21 6:45 AM

NYSE : DGX

Quest Diagnostics Debuts Next-Generation Lab Facility in Clifton, NJ

Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, has completed its integration of Northeast regional operations to its new 250,000 sq. ft. next-generation lab facility in Clifton, NJ. The

RHEA-AI

positive

10/05/21 8:30 AM

NYSE : DGX

covid-19

Quest Diagnostics and the Boston Athletic Association Team Up to Provide Onsite COVID-19 Diagnostic Testing for the 125th Boston Marathon

The Boston Athletic Association (B.A.A.) and Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that Quest will be the exclusive provider of onsite COVID-19 testing for the 125th

RHEA-AI

neutral

09/29/21 12:55 PM

NYSE : DGX

earnings

Quest Diagnostics To Release Third Quarter 2021 Financial Results On October 21

Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report third quarter 2021 financial results on Thursday, October 21, 2021, before the market opens. It will hold its

RHEA-AI

neutral

09/28/21 7:03 AM

NYSE : DGX

Over Half of U.S. Children Have Detectable Levels of Lead in their Blood, Finds Quest Diagnostics Health Trends® Study Published in JAMA Pediatrics

One in two (50.5%) American children under six years of age tested have detectable levels of lead, a toxic metal, in their blood, according to a new Health Trends® study from Quest Diagnostics (NYSE: DGX) released today and published in JAMA Pediatrics

RHEA-AI

neutral

09/09/21 6:45 AM

NYSE : DGX

Quest Diagnostics Updates Outlook For Full Year 2021

Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, today updated its financial outlook for full year 2021.Since the company reported its financial performance for the second quarter of 2021 on

RHEA-AI

neutral

08/31/21 11:19 AM

NYSE : DGX

covid-19

Cancer Diagnoses Declined Sharply During First Year of COVID-19 Pandemic, Finds Quest Diagnostics Health Trends® Study Published in JAMA Network Open

New diagnoses of eight common types of cancer (prostate, breast, colorectal, lung, pancreatic, cervical, gastric and esophageal) significantly declined during most of the first 13 months of the pandemic (March 2020- March 2021), according to a Health

RHEA-AI

neutral

08/30/21 11:18 AM

NYSE : DGX

conferences

Quest Diagnostics to Speak at the Morgan Stanley 19th Annual Global Healthcare Conference

Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley 19 th Annual Global Healthcare Conference. Steve Rusckowski, Chairman, CEO and

RHEA-AI

neutral

08/17/21 6:45 AM

NYSE : DGX

management

Quest Diagnostics Elects Tracey C. Doi to Board of Directors

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors has elected Ms. Tracey C. Doi to serve as a director. Including Ms. Doi, the company's Board has 10

RHEA-AI

neutral

08/16/21 6:30 PM

NYSE : DGX

dividends

Quest Diagnostics Declares Quarterly Cash Dividend

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.62 per share, payable on October 20, 2021 to shareholders of record

RHEA-AI

neutral

1 2 3 4 5 6 7 8 9 Next

DGX Data:

IndustryDental Laboratories
Websitewww.questdiagnostics.com
CeoStephen Rusckowski
Security nameQuest Diagnostics, Inc.
Issue typecs
SectorManufacturing
Sic code8071
Employees44500
Tags
- Health Services
- Services to the Health Industry
- Manufacturing
- Dental Laboratories
Address500 Plaza Dr
StateNew Jersey
CitySecaucus
Zip07094-3619
CountryUS
Phone19735202700

DGX Description:

Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.